Lv1
20 积分 2022-07-18 加入
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
2个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
2个月前
已完结
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy
2个月前
已完结
Inactivating the Innate Immune Receptor CD11b With a First-in-class Monoclonal Antibody Prolongs the Survival of Kidney Allografts in Nonhuman Primates
6个月前
已完结
Humanization of T cell–mediated immunity in mice
8个月前
已完结
Chemical strategies for brain delivery of genomic therapy
9个月前
已完结
Developing cell therapies for lupus
10个月前
已完结
Structure of the R2 non-LTR retrotransposon initiating target-primed reverse transcription
10个月前
已完结
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
10个月前
已完结
In vivo CRISPR screens identify key modifiers of CAR T cell function in myeloma
10个月前
已完结
皖公网安备34019202002308
